Enliven Therapeutics Stock News & Updates
[WKN: A3DGS0 | Symbol: ELVN]
Enliven Therapeutics
Enliven Therapeutics: The Cancer Specialist on the Brink of the Final Study Step
Tracking the Pivotal Point of Enliven Therapeutics (ELVN): Breakthrough in Precision Oncology – Mizuho Raises Price Target to $45!
Enliven Therapeutics is a clinical biotech company developing selective inhibitors for cancer treatment....
Enliven Therapeutics Reports Clinical Breakthrough in Therapy-Resistant Leukemia
Enliven Therapeutics is a clinically oriented biopharmaceutical company based in Boulder, Colorado, focused...
- ‹
- 1
- ›